526301 — Medinova Diagnostic Services Income Statement
0.000.00%
- IN₹389.28m
- IN₹404.60m
- IN₹98.13m
- 94
- 40
- 68
- 79
Annual income statement for Medinova Diagnostic Services, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 127 | 132 | 99.9 | 102 | 98.1 |
Cost of Revenue | |||||
Gross Profit | 112 | 107 | 87 | 91.6 | 91.7 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 105 | 100 | 77.2 | 75.1 | 69.6 |
Operating Profit | 22.9 | 31.6 | 22.7 | 26.5 | 28.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 19.6 | 28 | 19 | 22.8 | 25 |
Provision for Income Taxes | |||||
Net Income After Taxes | 19 | 23.8 | 16.7 | 20 | 19 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 20.2 | 22.7 | 16.7 | 20 | 19 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 20.2 | 22.7 | 16.7 | 20 | 19 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.03 | 2.27 | 1.67 | 2 | 1.89 |